Bachem (BANB SW) – FY sales 171.8m (vs 153.7m year ago) / EBIT 55.8m (vs cons 56.3m) / net profit 46.6m (vs cons 44.7m) / EBIT margin 32.4% (vs 30.7%). Outlook: expects clearly higher sales and earnings in the coming year – has targeted average sales expansion of 8-10% a year (BB)

SwissRe (RUKN VX) – SwissRe may save up to CHF 500m as a result of a structural change announced this week (FT)

Roche (ROG VX) – Trimeris and Roche amend research agreement covering next generation HIV fusion inhibitors (BB)

Schweiter (SWTQ SW) – AGM today and proposes a dividend pay out of CHF 6 (previous year CHF 3) (BB)

Swisscom (SCMN VX) – Mediaset now said all options open for Fastweb – this statement comes only a few days after company said no interest at all (BB)

Clariant (CLN VX) – UBS increase price target from CHF 15 to CHF 18, keep reduce rating (UBS research update)

Panalpina (PWTN SW) – UBS increase price target from CHF 200 to CHF 220, rating buy (UBS research update).